Gradient Investments’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-420
| Closed | -$5K | – | 1186 |
|
|
2020
Q2 | $5K | Hold |
420
| – | – | ﹤0.01% | 747 |
|
|
2020
Q1 | $6K | Sell |
420
-200
| -32% | -$2.86K | ﹤0.01% | 752 |
|
|
2019
Q4 | $17K | Hold |
620
| – | – | ﹤0.01% | 592 |
|
|
2019
Q3 | $18K | Buy |
620
+200
| +48% | +$5.81K | ﹤0.01% | 546 |
|
|
2019
Q2 | $12K | Hold |
420
| – | – | ﹤0.01% | 611 |
|
|
2019
Q1 | $14K | Hold |
420
| – | – | ﹤0.01% | 505 |
|
|
2018
Q4 | $12K | Hold |
420
| – | – | ﹤0.01% | 548 |
|
|
2018
Q3 | $19K | Hold |
420
| – | – | ﹤0.01% | 511 |
|
|
2018
Q2 | $16K | Hold |
420
| – | – | ﹤0.01% | 526 |
|
|
2018
Q1 | $12K | Hold |
420
| – | – | ﹤0.01% | 595 |
|
|
2017
Q4 | $14K | Buy |
+420
| New | +$14K | ﹤0.01% | 533 |
|
|
2017
Q3 | – | Sell |
-420
| Closed | -$11K | – | 533 |
|
|
2017
Q2 | $11K | Hold |
420
| – | – | ﹤0.01% | 467 |
|
|
2017
Q1 | $8K | Hold |
420
| – | – | ﹤0.01% | 546 |
|
|
2016
Q4 | $7K | Hold |
420
| – | – | ﹤0.01% | 501 |
|
|
2016
Q3 | $9K | Hold |
420
| – | – | ﹤0.01% | 469 |
|
|
2016
Q2 | $13K | Buy |
+420
| New | +$13K | ﹤0.01% | 395 |
|